Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2026-02-19 @ 5:41 AM
Study NCT ID:
NCT04194203
Status:
COMPLETED
Last Update Posted:
2024-07-19
First Post:
2019-12-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-27
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-09
First Submit QC Date:
None
Study First Post Date:
2019-12-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-18
Last Update Post Date:
2024-07-19
Last Update Post Date Type:
ACTUAL